Hepatitis B
Hepatitis B virus
hepatitis b

Hepatitis B is a serious disease caused by a virus that attacks the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death

CNO PDF 16 Aug 02
IMPLEMENTATION OF HEPATITIS B IMMUNIZATION FOR NEW ACCESSIONS
ALARACT PDF 04 Oct 94
HEPATITIS B VACCINATION
ALARACT PDF 05 Dec 91
REVISED HEPATITIS B VIRUS (HBV) IMMUNIZATION PROGRAM FOR THE AMEDD AND FOR SOLDIERS POSING IN KOREA
14 Nov 05

Sample Q&A: The Disease

Who is at risk for hepatitis B infection?

About 5% of people in the U.S. will get infected with hepatitis B sometime during their lives. If you engage in certain behaviors, your risk may be much higher. You may be at risk if you:

  • have a job that exposes you to human blood
  • share a household with someone who has lifelong hepatitis B infection
  • have sex with a person infected with hepatitis B
  • have sex with more than one partner during a six-month period
  • received blood transfusions in the past before excellent blood testing was available (1975)
  • are a person whose parents were born in Asia, Africa, the Amazon Basin of South America, the Pacific Islands, Eastern Europe, or the Middle East
  • were born in an area listed above
  • were adopted from an area listed above
  • are an Alaska native
  • have hemophilia
  • are a patient or worker in an institution for the developmentally disabled
  • inject drugs
  • are an inmate of a long-term correctional facility
  • travel internationally to areas with a high prevalence of hepatitis B

The largest outbreak of hepatitis B in the U.S. occurred in 1942 in military personnel who were given vaccine to protect them from yellow fever. It was unknown at the time that this vaccine contained a human blood component that was contaminated with hepatitis B virus. The outbreak caused over 50,000 cases of hepatitis B with jaundice.

Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: Immunization of Adults
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MSMR August 2012: Hospitalizations for Hepatitis A, B, and C, Active Component, U.S. Armed Forces,1991-2011
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP), Part II: Immunization of Adults
Recommendations of the Defense Health Board (DHB)
Recommendations of the Armed Forces Epidemiological Board (AFEB)
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Comvax (Merck) 01 Dec 10
Package Insert - Vaccine
Hepatitis B Recommendations for Adults
New NDC for GSK Hepatitis B Vaccine (Recombinant) in Prefilled Tip-Lok® Syringe
VIS
Vaccine Information Statement (Interim)
Vaccine Information Statement
Author(s): Wistrom J, Ahlm C, Lundberg S, Settergren B, Tarnvik A
Publication: Vaccine 17 (1999) 2162-2165
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Hadler S, de Monzon MA, Lugo DR, Perez M
Publication: Vaccine, vol. 7
Subject: Vaccine-Safety
Disease: Hepatitis B
Author(s): Marsano LS, West DJ, Chant I, Hesley TM, Cox J, Hackworth V, Greenberg RN
Publication: Vaccine. Vol. 16. No. 6, pp. 624-629
Subject: Vaccine-Effectiveness
Disease: Hepatitis B
Author(s): Jilg W, Schmidt M, Deinhardt F
Publication: Journal d Medical Virology 17:249-254
Subject: Vaccine-Effectiveness
Disease: Hepatitis B